A reagent kit for the determination of
immunoglobulins of class G (IgG) to the SARS-CoV*2 coronavirus that
causes COVID**9 in human serum (plasma) by the method of
enzyme-linked immunosorbent assay ELISA SARS-CoV*2 IgG Screen ", is
intended for the qualitative determination of antibodies of class G
(IgG) or for the qualitative simultaneous determination of
antibodies of class G (IgG) to the SARS-CoV*2 coronavirus causing
the" COVID**9 "disease in human blood serum (plasma) by applying
the method of solid-phase indirect enzyme-linked immunosorbent
assay (ELISA). The use of the reagent kit "SARS-CoV*2 IgG
Screen": • diagnosis of COVID**9 in patients with acute
respiratory syndrome; • identification of asymptomatic and
obliterated forms of COVID**9 in the foci of the
disease; • examination of SARS-CoV*2 virus
contacts; • examination of people arriving from regions
with a high level of COVID**9 disease and their re-examination
before leaving the observation; • identification of patients with COVID**9
regardless of the form of the infection process; • identification of potential donors of
high-volume plasma, which can be used in the treatment of severe
forms of COVID**9; • studies to determine the duration and
intensity of immunity to the SARS-CoV*2 virus.
